readthroughSign in
CompanyROIVNasdaqLondon

Roivant Sciences Ltd.

Roivant is a commercial-stage biopharmaceutical company developing small molecule and monoclonal antibody therapies.

10-QNov 10Latest SEC filing
Nov 10Latest story